Results 21 to 30 of about 2,835 (171)

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +4 more sources

Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder. [PDF]

Front Pharmacol, 2018
After a hiatus of some 40 years, clinical research has resumed on the use of classic hallucinogens to treat addiction. Following completion of a small open-label feasibility study, we are currently conducting a double-blind placebo-controlled clinical trial of psilocybin-assisted treatment of alcohol use disorder.
Bogenschutz MP, Podrebarac SK, Duane JH, Amegadzie SS, Malone TC, Owens LT, Ross S, Mennenga SE.   +7 more
europepmc   +6 more sources

Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report

Psychoactives
Psychedelic substances have experienced a resurgence of clinical interest in recent years, particularly for their promising effects in the treatment of psychiatric disorders such as depression and anxiety.
Mathilda Mercier, Cedric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia-Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler   +9 more
doaj   +4 more sources

Psilocybin‐assisted psychotherapy for treatment‐resistant depression: Which psychotherapy?

International Journal of Mental Health Nursing, 2023
AbstractThis perspective paper explores the choice of psychotherapy for psilocybin‐assisted psychotherapy for treatment‐resistant depression. There is evidence to support the use of some psychotherapies in treating ‘treatment‐resistant’ depression, and emerging evidence for the efficacy of psilocybin.
Marie Crowe, Jenni Manuel, Dave Carlyle   +2 more
exaly   +3 more sources

Psilocybin-Assisted Compassion Focused Therapy for Depression

Frontiers in Psychology, 2022
Psilocybin-assisted psychotherapy, i.e., psilocybin treatment with psychological support, has demonstrated the efficacy of psilocybin to reduce depressive symptoms.
Wendy Pots, Farid Chakhssi
doaj   +3 more sources

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder. [PDF]

Psychedelic Med (New Rochelle)
Background: Bipolar II disorder (BD-II) is often associated with chronic and treatment resistant major depressive episodes. Psilocybin has shown promise for its rapid-acting antidepressant effects, though its impact on bipolar depression remains unexplored.
Meshkat S, Kaczmarek E, Doyle Z, Brudner RM, Gomes FA, Blainey MG, Weiglein G, McIntyre RS, Mansur RB, Rosenblat JD.   +9 more
europepmc   +3 more sources

Psilocybin-assisted psychotherapy for treatment-resistant obsessive–compulsive disorder: protocol for an open-label pilot study [PDF]

BJPsych Open
Background Obsessive–compulsive disorder (OCD) is a debilitating mental disorder commonly treated with selective serotonin reuptake inhibitors, atypical antipsychotic augmentation and cognitive–behavioural therapy. However, up to 60% of people with OCD
Nicole Ledwos, Jenna Baer, Muhammad Ishrat Husain, Daniel M. Blumberger, Rachel Patterson, Elizabeth Hollingdrake, Ezmond Cheung, Colin Hawco, Christoph Zrenner, Brigitte Zrenner, Jamie D. Feusner, Susan L. Rossell, David J. Castle, Gwyneth Zai   +13 more
doaj   +2 more sources

Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study

EClinicalMedicine, 2020
Background: Psilocybin therapy has shown promise as a rapid-acting treatment for depression, anxiety, and demoralization in patients with serious medical illness (e.g., cancer) when paired with individual psychotherapy. This study assessed the safety and
Brian T Anderson, Alicia Danforth, Prof Robert Daroff, Christopher Stauffer, Eve Ekman, Gabrielle Agin-Liebes, Alexander Trope, Matthew Tyler Boden, Prof James Dilley, Jennifer Mitchell, Joshua Woolley   +10 more
doaj   +2 more sources

Psilocybin-assisted psychotherapy for cancer patients

The International Journal of Whole Person Care
Despite significant advances in symptom management for patients affected by serious illness, physicians lack effective legal treatments for individuals suffering from demoralization, death anxiety, and existential distress. Psilocybin-assisted psychotherapy employs psilocybin-containing mushrooms or synthetic psilocybin grounded in indigenous ...
Farzin, Houman
openaire   +3 more sources

Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement

BMJ Open
Introduction Prolonged grief disorder (PGD) represents a substantial public health issue, especially in oncology settings where it affects up to 30% of bereaved carers.
Jerome Sarris, Rachel E Neale, Jörg Strobel, Stephen Parker, Fiona Maccallum, Margaret Ross, Vanessa L Beesley, Susan L Rossell, Tom J Kennedy, Renee Harvey, Daniel Perkins, James Bennett-Levy, Shevaugn Johnson, Hanna Beebe, Natalie Roset   +14 more
doaj   +2 more sources